Lowe MC - Search Results

1

Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience.

Carr MJ, Sun J, DePalo D, Rothermel LD, Song Y, Straker RJ, Baecher K, Louie RJ, Stahlie EHA, Wright GP, Naqvi SMH, Kim Y, Sarnaik AA, Karakousis GC, Lowe MC, Delman KA, van Akkooi ACJ, Ollila DW, Collichio F, Zager JS. Carr MJ, et al. Among authors: lowe mc. Ann Surg Oncol. 2022 Feb;29(2):791-801. doi: 10.1245/s10434-021-10910-5. Epub 2021 Oct 14. Ann Surg Oncol. 2022. PMID: 34648098

2

Ipilimumab for advanced melanoma: let's not throw caution to the winds.

Lowe M, Delman KA. Lowe M, et al. Oncology (Williston Park). 2010 Dec;24(14):1296, 1299. Oncology (Williston Park). 2010. PMID: 21294473 No abstract available.

3

The impact of shave biopsy on the management of patients with thin melanomas.

Lowe M, Hill N, Page A, Chen S, Delman KA. Lowe M, et al. Am Surg. 2011 Aug;77(8):1050-3. Am Surg. 2011. PMID: 21944522

4

Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma.

Marcus DM, Lowe M, Khan MK, Lawson DH, Crocker IR, Shelton JW, Melton A, Maynard N, Delman KA, Carlson GW, Rizzo M. Marcus DM, et al. Am J Clin Oncol. 2014 Dec;37(6):580-4. doi: 10.1097/COC.0b013e318280d7be. Am J Clin Oncol. 2014. PMID: 23428955

5

Revisiting the Strait of Messina: The Balance Between Optimal Oncologic Outcomes and Complications From Surgery.

Delman KA, Lowe MC. Delman KA, et al. Among authors: lowe mc. Ann Surg Oncol. 2017 Feb;24(2):302-304. doi: 10.1245/s10434-016-5533-4. Epub 2016 Sep 12. Ann Surg Oncol. 2017. PMID: 27619941 No abstract available.

6

Morbidity and Outcomes Following Axillary Lymphadenectomy for Melanoma: Weighing the Risk of Surgery in the Era of MSLT-II.

Postlewait LM, Farley CR, Seamens AM, Le N, Rizzo M, Russell MC, Lowe MC, Delman KA. Postlewait LM, et al. Among authors: lowe mc. Ann Surg Oncol. 2018 Feb;25(2):465-470. doi: 10.1245/s10434-017-6242-3. Epub 2017 Nov 20. Ann Surg Oncol. 2018. PMID: 29159743

7

Recurrence Patterns after Primary Excision of Invasive Melanoma with Melanoma in situ at the Margin.

Oh G, Farley CR, Lopez-Aguiar AG, Russell MC, Delman KA, Lowe MC. Oh G, et al. Among authors: lowe mc. Am Surg. 2018 Aug 1;84(8):1319-1325. Am Surg. 2018. PMID: 30185309

8

ASO Author Reflections: Optimizing the Outcomes for Patients: The Evolution of the Management of Regional Disease in Patients with Melanoma.

Lowe MC, Farley CR, Delman KA. Lowe MC, et al. Ann Surg Oncol. 2018 Dec;25(Suppl 3):908-909. doi: 10.1245/s10434-018-6857-z. Epub 2018 Oct 8. Ann Surg Oncol. 2018. PMID: 30298327 No abstract available.

9

Neoadjuvant Treatments for Advanced Resectable Melanoma.

Liu JY, Lowe M. Liu JY, et al. J Surg Oncol. 2019 Jan;119(2):216-221. doi: 10.1002/jso.25352. Epub 2018 Dec 27. J Surg Oncol. 2019. PMID: 30589079 Review.

10

Real-World Outcomes of Talimogene Laherparepvec Therapy: A Multi-Institutional Experience.

Louie RJ, Perez MC, Jajja MR, Sun J, Collichio F, Delman KA, Lowe M, Sarnaik AA, Zager JS, Ollila DW. Louie RJ, et al. Among authors: lowe m. J Am Coll Surg. 2019 Apr;228(4):644-649. doi: 10.1016/j.jamcollsurg.2018.12.027. Epub 2019 Jan 25. J Am Coll Surg. 2019. PMID: 30690076

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page